FDA Play on Imaging3 (OTC: IMGG.OB): Revolutionary Medical Device Print E-mail
By Michael Vlaicu   
Sunday, 13 September 2009 20:34

Imaging3, Inc. (Public, OTC:IMGG) A new and radical medical device from Imaging3 Inc. (OTC:IMGG) is ready to set the standard, and revolutionize the way we look at X-ray, MRI and CT scans. Imaging 3 is currently awaiting FDA approval on their DViS (Dominion Volumetric Imaging Scanner).

Currently, medical imaging is met with challenges of long waits, lack of space, lack of mobility, and limited uses. However, for the first time ever, health-care workers will be able to instantly view 3D, high-resolution images of virtually any part of the human body. Thus, Imaging 3 looks to change all that. Saving time, saving lives and reducing costs. This technology will “set the standard for the next 10 years.” The following article was composed by StocksHaven Investments alongside Professor Philip Runfeldt, a Behavioral Analyst who has worked with Fortune 500 companies and major Universities throughout the Southeast.

About Imaging3 Inc. Imaging3, Inc. (Imaging3) is a medical device manufacturer, distributor and third-party service provider. The Company has developed a technology, known as Dominion, which utilizes photo-fluoroscopy to produce three dimensional (3D) medical diagnostic images in real time. Imaging3 is also a remanufacturer of C-arms. The Company offers new, demonstration, remanufactured, refurbished and pre-owned systems in all price ranges from every manufacturer, including OEC, General Electric (GE), ISI, Philips, Siemens, FluoroScan, XiScan and Ziehm. The Company supplies full-size, compact and mini C-arms.

The company was founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. According to the companies undisputed claims NO OTHER device provides 3D real time images. This means saving time and that accounts to saving lives. At a fraction of the cost for devices that do less it can be used in emergency rooms and urology procedures. Doctors want to see 3D images allowing for depth and direction perception whether performing diagnostic or interventional procedures. They now must utilize 2Dimaging that doesn’t allow for this.

Products Dominion Volumetric Imaging Scanner (DViS) Imagine for a moment a near-future health-care center equipped with Imaging3 devices. For the first time ever, health-care workers will be able to instantly view 3D, high-resolution images of virtually any part of the human body. Imaging3 Technology 3D images are instantly constructed using high-resolution fluoroscopy and can be used as real time references for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. The DViS will significantly alter the current medical imaging landscape by providing many benefits contained within one device.

  • True 3D Real-Time High Resolution Images
  • Mobile Form Factor Fits Through a Standard Room Door
  • No Shielded Room Required – Device Can Be Wheeled From OR To ER
  • Works on Standard 110v Wall Outlet Power
  • Emulates a 16-Slice CT Scanner at a Fraction of the Cost
  • Standard 2D Fluoroscopy - Still and Real-Time Imagery for Diagnostics
  • Multiple Pivot Points for Minimal Patient Movement
  • Standing Load-Bearing Imaging Capable
  • Price Point Well Below Existing CT Devices
  • Real Time Rendering Increases Facility Revenues Through Decreased Imaging Time
  • Image Capture at 30 Frames Per Second
  • Major Reduction in Exposure to Radiation
  • Broad Application Across Multiple Disciplines
  • Reduced Surgery Risk and Shorter Recovery Times
  • Enables New Procedures Not Possible Today
  • Increases Speed and Accuracy of Existing Procedures
  • Enables Less Invasive and More Precise Procedures

Imaging3 Technology has enormous potential to contribute to the improvement of health-care. It is representative of the disruptive technology that is changing health care in the 21st century. Smaller, faster, less expensive tools benefit doctors, patients, and facilities, as the merging of the technology and the health care industries create efficiencies and increased value.

Technology

Imaging3 has developed a breakthrough medical technology (patented) that will produce 3D medical diagnostic images in real time. Imaging3 Technology has enormous potential to contribute to the improvement of health-care. Imagine for a moment a future health-care center equipped with Imaging3 devices. For the first time ever, health-care workers will be able to instantly view 3D, high- resolution images of virtually any part of the human body. Imaging3 Technology 3D images are instantly constructed using high- resolution fluoroscopy and can be used as real time references for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body.

Multi-Function Device A diagnostic medical imaging device built with Imaging3 Technology can perform several functions and can replace or supplement a number of exiting devices, resulting in considerable cost savings for hospitals and healthcare centers. These functions include:


* Perform real time, 3D medical imaging * Emulate a CT scanner (at a fraction of the capital cost) * Perform standard fluoroscopy * Cross over to other modalities such as digital radiography The Company's management believes that this multi-function capability will be especially attractive in foreign markets, where the cost of a CT scanner is beyond the means of most hospitals and health-care centers.

Applications

Imaging3 Technology has extraordinary market potential in an almost unlimited number of medical applications. This ability to use this technology for multiple modalities dramatically increases the return on investment. For the full list, visit the company's website.

Computer Guided & Robotic Surgery Imaging3 Technology would provide a 3D image in real time with the addition of the P.A.I.L.S., Patient Anatomy Identification & Location Software, software the Physician could now have control of the image information and relate this information to any form of guided surgical technique to the patient. This would save a great deal of time, money and equipment used to interface with existing equipment as well as equipment being developed in the future.

Cardiology Imaging3 Technology could provide a 3D view of a heart and allow a cardiologist to record the heartbeat in real-time. The entire heart would be visible, including veins that are wrapped around the "back" side.

Computer Guided & Robotic Surgery By adding Patient Anatomy Identification & Location Software (PAILS) to Imaging3 Technology, the Physician could then have control of the image information and relate this information to any form of guided surgical technique to the patient. This feature would save a great deal of time, money and equipment used to interface with existing equipment as well as equipment being developed in the future.

Sports Medicine Imaging3 Technology would provide real time 3D imaging to Sports Medicine Practitioners whose patients range from Soccer Moms to Sports Celebrities. Giving these Physicians information in 3D real time increased diagnostic accuracy as well as increasing throughput and quality of patient care.

Pediatrics Imaging3 Technology would provide a real time 3D with a dose lower than standard fluoroscopy. The benefits of being able to diagnose children quickly and with a lower dose would be very attractive to any facility.

Urology Imaging3 Technology would provide a real time 3D image of the cervical space and associated organs, better enabling the Physicians to perform delicate diagnostic and interventional procedures.

Target Market

Imaging3 competes in the medical diagnostic imaging market and this market has never been healthier than it is today. This vitality is due primarily to continual technological improvements that lead to faster and better-resolution imaging, greater patient safety, and the provision of these capabilities to a growing population. The result has been a vigorous competition to create the most cost-effective diagnostic imaging systems.

According to a Freedonia Group study, the medical imaging equipment market in the US will register gains of 7.6 percent per year through 2008 to $9.5 billion, faster than projected growth in national health expenditures. Growth will be stimulated by an increasing incidence of patient procedures involving diagnostic imaging, partly the result of an aging population and partly reflecting advances in noninvasive imaging technology.

Diagnostic imaging is an evolving part of modern medicine and is now entering a new era of digital imaging. The field has evolved from the early X-rays by Roentgen over 100 years ago to imaging of organs by computerized tomography (CT) and magnetic resonance imaging (MRI) that are 20 years old. Medical imaging is used for diagnosis in the leading causes of death, heart attacks, strokes, and cancer. What was once called the radiology department is now called the diagnostic imaging department because of the wealth of new technologies available beyond x-rays. A trauma victim's internal injuries are imaged with a CT scanner.

Dominion VI Scanner has No Direct Competitors At this time, the Company's management is not aware of any existing devices in the marketplace that provide 3D, real-time diagnostic medical imaging, with the exception of ultrasound. Ultrasound is a real-time tomographic imaging modality. Not only does it produce real-time tomograms of the position of reflecting surfaces (internal organs and structures), but also it can be used to produce real-time images of tissue and blood motion. However, ultrasound is a low-resolution imaging modality that does not produce an image as precise and clear as fluoroscopy. The Company's invention relies instead on the use of fluoroscopy, a high-resolution imaging modality, to produce a "live" X-ray image of a living patient in 3D.

FDA Status & CEO Conference Call In the last conference call on 19/08/09, CEO Dean Janes stated that the FDA had requested some images previously not asked for. It was confirmed that these images would be provided around the second week of September. This may be the reason the company's stock (OTC:IMGG) set an all-time record volume of 8,018,490 shares traded on 09/11/09.

Expecting the images to be submitted soon, if not already. Since the CEO has stated that approval could come as soon as 15 days post submission, many investors do not want to be caught offguard without shares once approval is announced. IMGG could release the news at anytime with regards to submission or communication with the FDA creating a sense of urgency. Moreover, many distributors stated they were '"blown away" by the Dominion and there was nothing like it. These are the professionals who know the devices, their capabilities and what sells in today's market. They definitely expressed extreme eagerness at being a possible distributor soon.

The CEO, Dean Janes, a biomedical engineer previously explained that 'elite' centers across the country would be set up as "Luminary Sites" where, purchasers would go to talk to the physicians initially using the device and see the Dominion in real world application and purchase through these sites. The idea to have the best medical centers in the country sell the devices rather than having to 'chase down' prospects speaks for the high demand this device is expected to have and why existing distributors are actively seeking ways to sell the devices themselves. To listen to the Conference Call, visit the company's website.

C-Arms It is important to note that Imaging3 is the largest worldwide remanufacturer of C-Arms. They offer new, demo, remanufactured, refurbished, and pre-owned systems in all price ranges. To learn more about this technology, or if you are interested in making a purchase, visit the C-Arm company's website section.

Technical Chart Analysis In the past month there has been over a 4000% increase in daily volume for IMGG and this clearly indicates a growing interest in this company and it's activities. Also in the past month, price has increased over 385% while establishing a well defined and rising price channel shown in Blue on the chart. On Friday (9/11/09), the price clearly broke a strong level of resistance at .10 cents (shown in the Red circle on the chart) that was established a year ago!

This event is also important since the .10 cent price represents the 50% retracement level of a Fibonacci Analysis performed on the significant movement from Wednesday morning to Thursday morning during the first week of this month (August 2009). This was the third time the price has come up to that 50% line. It has been observed that the third time actually is the charm and usually indicates the price has had time to consolidate after a big move, will break the trend-line, and will stay above it. With all the growing interest and strong bullish signals, the stock appears ready to make a run to the top of the new price channel and easily beyond if there is FDA approval. It’s good to keep in the back of your mind that the last two times the stock closed at the .20 cent level, it jumped above .30 cents within a day’s time. That would be over a 100% gain from where the price closed on Friday.

Imaging3 Gaining Exposure If this information is not enough to entice your interest in the company, lets take a look at the worldwide exposure the company has been gaining on MoneyTV and Health This Week. Here are some clips which further emphasize the revolutionary breakthrough product. Overall Sentiment With the company expecting FDA news at anytime, and exposure on the company's potential rising fast, the now question becomes - What is there not to like about this company? A bright CEO in Dean Janes, along with a dedicated staff of executives and research assistants give this company a bright future ahead. Add on to this the fact that Reuters has given the company its top Analyst Recommendation rating, and you have yourself a winner both in the short-term, and long-term. ———–

Disclosure: Both, StocksHaven Investments and Professor Runfeldt are LONG IMGG



"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus
 

Newsletter